Advertisement

Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism

      Pulmonary embolism (PE) can result in rapid clinical decompensation in many patients. With increasing patient complexity and advanced treatment options for PE, multidisciplinary, rapid response teams can optimize risk stratification and expedite management strategies. The Massive And Submassive Clot On-call Team (MASCOT) was created at our institution, which comprised specialists from cardiology, pulmonology, hematology, interventional radiology, and cardiac surgery. MASCOT offers rapid consultation 24 hours a day with a web-based conference call to review patient data and discuss management of patients with high-risk PE. We reviewed patient data collected from MASCOT's registry to analyze patient clinical characteristics and outcomes and describe the composition and operation of the team. Between August 2015 and September 2016, MASCOT evaluated 72 patients. Seventy of the 72 patients were admitted to our institution, accounting for 32% of all patients discharged with a primary diagnosis of PE. Average age was 62 ± 17 years with a female predominance (63%). Active malignancy (31%), recent surgery or trauma (21%), and recent hospitalization (24%) were common. PE clinical severity was massive in 16% and submassive in 83%. Patients were managed with anticoagulation alone in 65% (n = 46), systemic fibrinolysis in 11% (n = 8), catheter-directed therapy in 18% (n = 13), extracorporeal membrane oxygenation in 3% (n = 2), and an inferior vena cava filter was placed in 15% (n = 11). Thirteen percent (n = 9) experienced a major bleed with no intracranial hemorrhage. Survival to discharge was 89% (64% with massive PE and 93% with submassive PE). In conclusion, multidisciplinary, rapid response PE teams offer a unique coordinated approach to patient care.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jimenez D.
        • de Miguel-Diez J.
        • Guijarro R.
        • Trujillo-Santos J.
        • Otero R.
        • Barba R.
        • Muriel A.
        • Meyer G.
        • Yusen R.D.
        • Monreal M.
        Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry.
        J Am Coll Cardiol. 2016; 67: 162-170
        • Huang W.
        • Goldberg R.J.
        • Anderson F.A.
        • Kiefe C.I.
        • Spencer F.A.
        Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985–2009).
        Am J Med. 2014; 127: 829-839
        • Cohen A.T.
        • Agnelli G.
        • Anderson F.A.
        • Arcelus J.I.
        • Bergqvist D.
        • Brecht J.G.
        • Greer I.A.
        • Heit J.A.
        • Hutchinson J.L.
        • Kakkar A.K.
        • Mottier D.
        • Oger E.
        • Samama M.M.
        • Spannagl M.
        Venous thromboembolism in Europe. The number of VTE events and associated morbidity and mortality.
        Thromb Haemost. 2007; 98: 756-764
        • Mahe I.
        • Chidiac J.
        • Bertoletti L.
        • Font C.
        • Trujillo-Santos J.
        • Peris M.
        • Perez Ductor C.
        • Nieto S.
        • Grandone E.
        • Monreal M.
        The clinical course of venous thromboembolism may differ according to cancer site.
        Am J Med. 2016; 130: 337-347
        • Monreal M.
        • Munoz-Torrero J.F.
        • Naraine V.S.
        • Jimenez D.
        • Soler S.
        • Rabunal R.
        • Gallego P.
        Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure.
        Am J Med. 2006; 119: 851-858
        • Stein P.D.
        • Matta F.
        Treatment of unstable pulmonary embolism in the elderly and those with comorbid conditions.
        Am J Med. 2013; 126: 304-310
        • Stein P.D.
        • Matta F.
        Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused.
        Am J Med. 2012; 125: 465-470
        • Piazza G.
        • Hohlfelder B.
        • Jaff M.R.
        • Ouriel K.
        • Engelhardt T.C.
        • Sterling K.M.
        • Jones N.J.
        • Gurley J.C.
        • Bhatheja R.
        • Kennedy R.J.
        • Goswami N.
        • Natarajan K.
        • Rundback J.
        • Sadiq I.R.
        • Liu S.K.
        • Bhalla N.
        • Raja M.L.
        • Weinstock B.S.
        • Cynamon J.
        • Elmasri F.F.
        • Garcia M.J.
        • Kumar M.
        • Ayerdi J.
        • Soukas P.
        • Kuo W.
        • Liu P.Y.
        • Goldhaber S.Z.
        A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study.
        JACC Cardiovasc Interv. 2015; 8: 1382-1392
        • Jaber W.A.
        • Fong P.P.
        • Weisz G.
        • Lattouf O.
        • Jenkins J.
        • Rosenfield K.
        • Rab T.
        • Ramee S.
        Acute pulmonary embolism: with an emphasis on an interventional approach.
        J Am Coll Cardiol. 2016; 67: 991-1002
        • Carroll B.J.
        • Shah R.V.
        • Murthy V.
        • McCullough S.A.
        • Reza N.
        • Thomas S.S.
        • Song T.H.
        • Newton-Cheh C.H.
        • Camuso J.M.
        • MacGillivray T.
        • Sundt T.M.
        • Semigran M.J.
        • Lewis G.D.
        • Baker J.N.
        • Garcia J.P.
        Clinical features and outcomes in adults with cardiogenic shock supported by extracorporeal membrane oxygenation.
        Am J Cardiol. 2015; 116: 1624-1630
        • Konstantinides S.V.
        • Torbicki A.
        • Agnelli G.
        • Danchin N.
        • Fitzmaurice D.
        • Galie N.
        • Gibbs J.S.
        • Huisman M.V.
        • Humbert M.
        • Kucher N.
        • Lang I.
        • Lankeit M.
        • Lekakis J.
        • Maack C.
        • Mayer E.
        • Meneveau N.
        • Perrier A.
        • Pruszczyk P.
        • Rasmussen L.H.
        • Schindler T.H.
        • Svitil P.
        • Vonk Noordegraaf A.
        • Zamorano J.L.
        • Zompatori M.
        2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
        Eur Heart J. 2014; 35: 3033-3069
        • Kearon C.
        • Akl E.A.
        • Ornelas J.
        • Blaivas A.
        • Jimenez D.
        • Bounameaux H.
        • Huisman M.
        • King C.S.
        • Morris T.A.
        • Sood N.
        • Stevens S.M.
        • Vintch J.R.
        • Wells P.
        • Woller S.C.
        • Moores L.
        Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report.
        Chest. 2016; 149: 315-352
        • Casazza F.
        • Becattini C.
        • Bongarzoni A.
        • Cuccia C.
        • Roncon L.
        • Favretto G.
        • Zonzin P.
        • Pignataro L.
        • Agnelli G.
        Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER).
        Thromb Res. 2012; 130: 847-852
        • Naess I.A.
        • Christiansen S.C.
        • Romundstad P.
        • Cannegeiter S.C.
        • Rosendaal F.R.
        • Hammerstrom J.
        Incidence and mortality of venous thrombosis: a population-based study.
        J Thromb Haemost. 2007; 5: 692-699
        • Huang W.
        • Goldberg R.J.
        • Cohen A.T.
        • Anderson F.A.
        • Kiefe C.I.
        • Gore J.M.
        • Spencer F.A.
        Declining long-term risk of adverse events after first-time community-presenting venous thromboembolism: the population-based Worcester VTE study (1999 to 2009).
        Thromb Res. 2015; 135: 1100-1106
        • Berwick D.M.
        • Calkins D.R.
        • McCannon C.J.
        • Hackbarth B.A.
        The 100 000 lives campaign: setting a goal and a deadline for improving health care quality.
        JAMA. 2006; 295: 324-327
        • Solomon R.S.
        • Corwin G.S.
        • Barclay D.C.
        • Quddusi S.F.
        • Dannenberg M.D.
        Effectiveness of rapid response teams on rates of in-hospital cardiopulmonary arrest and mortality: a systematic review and meta-analysis.
        J Hosp Med. 2016; 11: 438-445
        • Kabrhel C.
        • Rosovsky R.
        • Channick R.
        • Jaff M.R.
        • Weinberg I.
        • Sundt T.
        • Dudzinski D.M.
        • Rodriguez-Lopez J.
        • Parry B.A.
        • Harshbarger S.
        • Chang Y.
        • Rosenfield K.
        A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism.
        Chest. 2016; 150: 384-393
        • Barnes G.D.
        • Kabrhel C.
        • Courtney D.M.
        • Naydenov S.
        • Wood T.
        • Rosovsky R.
        • Rosenfield K.
        • Giri J.
        Diversity in the pulmonary embolism response team model: an organizational survey of the national PERT consortium members.
        Chest. 2016; 150: 1414-1417
        • Bloomer T.L.
        • Thomassee E.J.
        • Fong P.P.
        Acute pulmonary embolism network and multidisciplinary response team approach to treatment.
        Crit Pathw Cardiol. 2015; 14: 90-96
        • Jaff M.R.
        • McMurtry M.S.
        • Archer S.L.
        • Cushman M.
        • Goldenberg N.
        • Goldhaber S.Z.
        • Jenkins J.S.
        • Kline J.A.
        • Michaels A.D.
        • Thistlethwaite P.
        • Vedantham S.
        • White R.J.
        • Zierler B.K.
        Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.
        Circulation. 2011; 123: 1788-1830
        • GUSTO Investigators
        An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
        N Engl J Med. 1993; 329: 673-682
        • Sharifi M.
        • Bay C.
        • Skrocki L.
        • Rahimi F.
        • Mehdipour M.
        Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial).
        Am J Cardiol. 2013; 111: 273-277
        • Jones D.A.
        • DeVita M.A.
        • Bellomo R.
        Rapid-response teams.
        N Engl J Med. 2011; 365: 139-146
        • Sayer G.T.
        • Baker J.N.
        • Parks K.A.
        Heart rescue: the role of mechanical circulatory support in the management of severe refractory cardiogenic shock.
        Curr Opin Crit Care. 2012; 18: 409-416
        • Aujesky D.
        • Obrosky S.
        • Stone R.A.
        • Auble T.E.
        • Arnaud P.
        • Cornuz J.
        • Roy P.M.
        • Fine M.J.
        Derivation and validation of a prognostic model for pulmonary embolism.
        Am J Respir Crit Care Med. 2005; 172: 1041-1046
        • Pillay B.
        • Wootten A.C.
        • Crowe H.
        • Corcoran N.
        • Tran B.
        • Bowden P.
        • Crowe J.
        • Costello A.J.
        The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature.
        Cancer Treat Rev. 2016; 42: 56-72
        • Holmes Jr, D.R.
        • Rich J.B.
        • Zoghbi W.A.
        • Mack M.J.
        The heart team of cardiovascular care.
        J Am Coll Cardiol. 2013; 61: 903-907
        • Goldhaber S.Z.
        • Visani L.
        • De Rosa M.
        Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).
        Lancet. 1999; 353: 1386-1389